Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Atorvastatin recalled?

Yes — there is an active recall. 8 ongoing FDA recalls mention Atorvastatin (67 total). Check the affected lots below.

Most common reason: Impurity / degradation (14 of these recalls)

Recalls are matched by product description. A recall usually affects specific lots, not every package of Atorvastatin. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Atorvastatin recalls on record

none so far in 2026; 67 on record, newest first
Class II · Moderate risk

Atorvastatin Calcium Tablets

Presence of Foreign Tablets/Capsules: A Carbamazepine Extended-Release 400 mg tablet was found in a 1000-count bottle of Atorvastatin Calcium Tablets, USP 40 mg.

Terminated Particulate / foreign matter Nivagen Pharmaceuticals Inc D-0001-2025
Class II · Moderate risk

Atorvastatin Calcium Tablets

cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.

Ongoing cGMP deviation Preferred Pharmaceuticals, Inc. NDC 68788-7631-9 D-0512-2023
Class II · Moderate risk

Atorvastatin Calcium Tablets

cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.

Ongoing cGMP deviation Preferred Pharmaceuticals, Inc. NDC 68788-7630-9 D-0511-2023
Class III · Low risk

Atorvastatin Calcium Tablets

Failed Impurities/Degradation Specifications: due to presence of ATV cyclo IP and FP impurities

Terminated Impurity / degradation Dr. Reddy's Laboratories, Inc. NDC 55111-121-05 D-0629-2021
Class III · Low risk

Atorvastatin Calcium Tablets

Failed Impurities -Degradation Specifications:due to presence of ATV cyclo IP and FP impurities

Terminated Impurity / degradation Dr. Reddy's Laboratories, Inc. NDC 55111-121-05 D-0599-2021
Class III · Low risk

Atorvastatin Calcium Tablets

Failed Impurities/Degradation Specifications:presence of ATV cyclo IP and FP, Dihydroxy epoxy and Dieto epoxy impurities

Terminated Impurity / degradation Dr. Reddy's Laboratories, Inc. NDC 55111-123-90 D-0291-2021
Class II · Moderate risk

Atorvastatin Calcium Tablets

Presence of foreign substance: Foreign matter has been identified as latex glove in one lot of Atorvastatin Calcium Tablets USP 40 mg.

Terminated Particulate / foreign matter Sun Pharmaceutical Industries, Inc. NDC 63304-829-05 D-1047-2020
Class II · Moderate risk

Caduet (amlodipine besylate/atorvastatin calcium)

Defective Container: products potentially could have been packaged in defective bottles, with a notched rim, that could cause inadequate foil sealing resulting in lack of moisture protection.

Terminated Packaging defect Pfizer Inc. NDC 0069-2160-30 D-0842-2020
Class II · Moderate risk

Caduet (amlodipine besylate/atorvastatin calcium)

Defective Container: products potentially could have been packaged in defective bottles, with a notched rim, that could cause inadequate foil sealing resulting in lack of moisture protection.

Terminated Packaging defect Pfizer Inc. NDC 0069-2180-30 D-0841-2020
Class II · Moderate risk

Atorvastatin Calcium Tablets

Presence of Foreign Tablets/Capsules: Customer complaint that one 20 mg Atorvastatin Calcium Tablet was present in a bottle labeled as and containing eight-nine Atorvastatin Calcium Tablets, USP 10 mg.

Terminated Particulate / foreign matter Graviti Pharmaceuticals Private Limited NDC 70377-027-11 D-0832-2020
Class III · Low risk

Atorvastatin Calcium tablets

Failed Impurities/Degradation Specifications - OOS was observed for ATV Cyclo FP Impurity and Total Degradation Impurities tested at the 18 month stability time point in Atorvastatin Calcium Tablets 40 mg 500 tablets.

Terminated Impurity / degradation Dr. Reddy's Laboratories, Inc. NDC 55111-123-05 D-1079-2018